Nuveen Floating Rate Income Fund, MPLX LP, Another 8 Companies Have A High Estimated Dividend Yield

(VIANEWS) – Nuveen Floating Rate Income Fund (JFR), MPLX LP (MPLX), Hennessy Advisors (HNNA) have the highest dividend yield stocks on this list.

Almost 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. Nuveen Floating Rate Income Fund (JFR) – Dividend Yield: 11.86%

Nuveen Floating Rate Income Fund’s last close was $8.65, 0.46% under its 52-week high of $8.69. Intraday change was 0.58%.

Nuveen Floating Rate Income Fund is a close ended fixed income mutual fund launched by Nuveen Investments, Inc. It is co-managed by Nuveen Fund Advisors LLC and Symphony Asset Management LLC. The fund invests in fixed income markets of the United States. It primarily invests in adjustable rate secured and unsecured senior loans. Nuveen Floating Rate Income Fund was formed on March 24, 2004 and is domiciled in the United States.

Earnings Per Share

As for profitability, Nuveen Floating Rate Income Fund has a trailing twelve months EPS of $-0.3.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.97%.

Volume

Today’s last reported volume for Nuveen Floating Rate Income Fund is 705259 which is 0.17% below its average volume of 706473.

Moving Average

Nuveen Floating Rate Income Fund’s value is higher than its 50-day moving average of $8.35 and higher than its 200-day moving average of $8.08.

More news about Nuveen Floating Rate Income Fund.

2. MPLX LP (MPLX) – Dividend Yield: 8.72%

MPLX LP’s last close was $40.42, 1.18% above its 52-week high of $39.95. Intraday change was -0.7%.

MPLX LP owns and operates midstream energy infrastructure and logistics assets primarily in the United States. It operates in two segments, Logistics and Storage, and Gathering and Processing. The company is involved in the gathering, processing, and transportation of natural gas; gathering, transportation, fractionation, exchange, storage, and marketing of natural gas liquids; gathering, storage, transportation, and distribution of crude oil and refined products, as well as other hydrocarbon-based products; and sale of residue gas and condensate. It also engages in the inland marine businesses comprising transportation of light products, heavy oils, crude oil, renewable fuels, chemicals, and feedstocks in the Mid-Continent and Gulf Coast regions, as well as owns and operates boats and barges, including third-party chartered equipment, and a marine repair facility located on the Ohio River; and distribution of fuel, as well as operates refining logistics, terminals, rail facilities, and storage caverns. In addition, the company operates terminal facilities for the receipt, storage, blending, additization, handling, and redelivery of refined petroleum products through the pipeline, rail, marine, and over-the-road modes of transportation. MPLX GP LLC acts as the general partner of MPLX LP. The company was incorporated in 2012 and is headquartered in Findlay, Ohio. MPLX LP operates as a subsidiary of Marathon Petroleum Corporation.

Earnings Per Share

As for profitability, MPLX LP has a trailing twelve months EPS of $3.8.

PE Ratio

MPLX LP has a trailing twelve months price to earnings ratio of 10.61. Meaning, the purchaser of the share is investing $10.61 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.56%.

More news about MPLX LP.

3. Hennessy Advisors (HNNA) – Dividend Yield: 8.18%

Hennessy Advisors’s last close was $6.72, 19.62% below its 52-week high of $8.36. Intraday change was -0.44%.

Hennessy Advisors, Inc. is an employee owned investment manager. It provides its services to Hennessy Funds and investment companies. The firm launches and manages equity, fixed income, and balanced mutual funds. It invests in the public equity and fixed income markets across the globe. The firm primarily invests in growth stocks of companies. It conducts in-house research to make its investments. Hennessy Advisors, Inc. was founded in 1989 and is based in Novato, California with additional offices in Boston, Massachusetts and Chapel Hill, North Carolina.

Earnings Per Share

As for profitability, Hennessy Advisors has a trailing twelve months EPS of $0.64.

PE Ratio

Hennessy Advisors has a trailing twelve months price to earnings ratio of 10.5. Meaning, the purchaser of the share is investing $10.5 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.55%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Feb 16, 2024, the estimated forward annual dividend rate is 0.55 and the estimated forward annual dividend yield is 8.18%.

More news about Hennessy Advisors.

4. Pfizer (PFE) – Dividend Yield: 6.32%

Pfizer’s last close was $26.79, 36.55% below its 52-week high of $42.22. Intraday change was 1.53%.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Earnings Per Share

As for profitability, Pfizer has a trailing twelve months EPS of $0.37.

PE Ratio

Pfizer has a trailing twelve months price to earnings ratio of 73.51. Meaning, the purchaser of the share is investing $73.51 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.35%.

Volatility

Pfizer’s last week, last month’s, and last quarter’s current intraday variation average was 1.64%, 0.15%, and 1.33%.

Pfizer’s highest amplitude of average volatility was 2.99% (last week), 1.29% (last month), and 1.33% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 57.7% and a negative 32.8%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth declined by 41.3%, now sitting on 58.5B for the twelve trailing months.

Volume

Today’s last reported volume for Pfizer is 35122800 which is 28.77% below its average volume of 49313900.

More news about Pfizer.

5. Nuveen Municipal Income Fund (NMI) – Dividend Yield: 4.43%

Nuveen Municipal Income Fund’s last close was $9.21, 8.36% below its 52-week high of $10.05. Intraday change was -0.11%.

Nuveen Municipal Income Fund, Inc. is a closed ended fixed income mutual fund launched by Nuveen Investments Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of the United States. The fund primarily invests in municipal obligations issued by state and local government authorities. Its investment portfolio comprises investment in companies operating in various industries, including healthcare, materials, education and civic organizations, and consumer staples. Nuveen Municipal Income Fund was formed on April 20, 1988 and is based in the United States.

Earnings Per Share

As for profitability, Nuveen Municipal Income Fund has a trailing twelve months EPS of $0.29.

PE Ratio

Nuveen Municipal Income Fund has a trailing twelve months price to earnings ratio of 31.72. Meaning, the purchaser of the share is investing $31.72 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.15%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Feb 14, 2024, the estimated forward annual dividend rate is 0.41 and the estimated forward annual dividend yield is 4.43%.

More news about Nuveen Municipal Income Fund.

6. Acadia Realty Trust (AKR) – Dividend Yield: 4.35%

Acadia Realty Trust’s last close was $16.40, 7.5% under its 52-week high of $17.73. Intraday change was -0.97%.

Acadia Realty Trust is an equity real estate investment trust focused on delivering long-term, profitable growth via its dual – Core and Fund – operating platforms and its disciplined, location-driven investment strategy. Acadia Realty Trust is accomplishing this goal by building a best-in-class core real estate portfolio with meaningful concentrations of assets in the nation's most dynamic corridors; making profitable opportunistic and value-add investments through its series of discretionary, institutional funds; and maintaining a strong balance sheet.

Earnings Per Share

As for profitability, Acadia Realty Trust has a trailing twelve months EPS of $0.2.

PE Ratio

Acadia Realty Trust has a trailing twelve months price to earnings ratio of 82. Meaning, the purchaser of the share is investing $82 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.08%.

Sales Growth

Acadia Realty Trust’s sales growth is 50.8% for the present quarter and 67.4% for the next.

Revenue Growth

Year-on-year quarterly revenue growth declined by 10.3%, now sitting on 332M for the twelve trailing months.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Dec 28, 2023, the estimated forward annual dividend rate is 0.72 and the estimated forward annual dividend yield is 4.35%.

Moving Average

Acadia Realty Trust’s worth is below its 50-day moving average of $16.98 and higher than its 200-day moving average of $15.18.

More news about Acadia Realty Trust.

7. Ameren (AEE) – Dividend Yield: 3.76%

Ameren’s last close was $73.01, 19.93% below its 52-week high of $91.18. Intraday change was -0.04%.

Ameren Corporation, together with its subsidiaries, operates as a public utility holding company in the United States. The company operates through four segments: Ameren Missouri, Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission. It engages in the rate-regulated electric generation, transmission, and distribution activities; and rate-regulated natural gas distribution and transmission businesses. In addition, the company generates electricity through coal, nuclear, and natural gas, as well as renewable sources, such as hydroelectric, wind, methane gas, and solar. It serves residential, commercial, and industrial customers. The company was founded in 1881 and is headquartered in Saint Louis, Missouri.

Earnings Per Share

As for profitability, Ameren has a trailing twelve months EPS of $4.38.

PE Ratio

Ameren has a trailing twelve months price to earnings ratio of 16.68. Meaning, the purchaser of the share is investing $16.68 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.46%.

Moving Average

Ameren’s value is higher than its 50-day moving average of $70.82 and under its 200-day moving average of $77.64.

Sales Growth

Ameren’s sales growth is negative 20.9% for the present quarter and 4.1% for the next.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Mar 12, 2024, the estimated forward annual dividend rate is 2.68 and the estimated forward annual dividend yield is 3.76%.

Volume

Today’s last reported volume for Ameren is 868275 which is 60.9% below its average volume of 2221050.

More news about Ameren.

8. Westamerica Bancorporation (WABC) – Dividend Yield: 3.64%

Westamerica Bancorporation’s last close was $48.38, 16.53% below its 52-week high of $57.96. Intraday change was 1.36%.

Westamerica Bancorporation operates as a bank holding company for the Westamerica Bank that provides various banking products and services to individual and commercial customers. The company accepts various deposit products, including retail savings and checking accounts, as well as certificates of deposit. Its loan portfolio includes commercial, commercial and residential real estate, real estate construction, and consumer installment loans, as well as other loans primarily consisting of indirect automobile loans. Westamerica Bancorporation operates through 79 branch offices in 21 counties in Northern and Central California. The company was formerly known as Independent Bankshares Corporation and changed its name to Westamerica Bancorporation in 1983. Westamerica Bancorporation was founded in 1972 and is headquartered in San Rafael, California.

Earnings Per Share

As for profitability, Westamerica Bancorporation has a trailing twelve months EPS of $6.06.

PE Ratio

Westamerica Bancorporation has a trailing twelve months price to earnings ratio of 7.98. Meaning, the purchaser of the share is investing $7.98 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.53%.

Volume

Today’s last reported volume for Westamerica Bancorporation is 129885 which is 23.45% below its average volume of 169680.

Moving Average

Westamerica Bancorporation’s value is under its 50-day moving average of $49.32 and above its 200-day moving average of $46.60.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 9.3% and a negative 11.3%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 1.5%, now sitting on 324.52M for the twelve trailing months.

More news about Westamerica Bancorporation.

9. Smith & Nephew (SNN) – Dividend Yield: 2.84%

Smith & Nephew’s last close was $27.65, 16.44% below its 52-week high of $33.09. Intraday change was 0.22%.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products, including instruments, technologies, and implants to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Earnings Per Share

As for profitability, Smith & Nephew has a trailing twelve months EPS of $0.6.

PE Ratio

Smith & Nephew has a trailing twelve months price to earnings ratio of 46. Meaning, the purchaser of the share is investing $46 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.02%.

Volume

Today’s last reported volume for Smith & Nephew is 693304 which is 25.7% below its average volume of 933195.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Oct 5, 2023, the estimated forward annual dividend rate is 0.75 and the estimated forward annual dividend yield is 2.84%.

Yearly Top and Bottom Value

Smith & Nephew’s stock is valued at $27.60 at 16:15 EST, way under its 52-week high of $33.09 and way higher than its 52-week low of $21.53.

More news about Smith & Nephew.

10. Hanover Insurance Group (THG) – Dividend Yield: 2.64%

Hanover Insurance Group’s last close was $128.87, 6.62% below its 52-week high of $138.00. Intraday change was -1.98%.

The Hanover Insurance Group, Inc., through its subsidiaries, provides various property and casualty insurance products and services in the United States. The company operates through four segments: Core Commercial, Specialty, Personal Lines, and Other. The Commercial Lines segment offers commercial multiple peril, commercial automobile, workers' compensation, and other commercial lines coverage. The Specialty segment provides professional and executive Lines, marine, and surety and other, as well as specialty P&C, such as program business, specialty industrial and commercial property, excess and surplus lines, and specialty general liability coverage. The Personal Lines segment offers personal automobile and homeowner's coverages, as well as other personal coverages, such as personal umbrella, inland marine, fire, personal watercraft, personal cyber, and other miscellaneous coverages. The Other segment markets investment management services to institutions, pension funds, and other organizations. The Hanover Insurance Group, Inc. markets its products and services through independent agents and brokers. The company was formerly known as Allmerica Financial Corp. and changed its name to The Hanover Insurance Group, Inc. in December 2005. The Hanover Insurance Group, Inc. was founded in 1852 and is headquartered in Worcester, Massachusetts.

Earnings Per Share

As for profitability, Hanover Insurance Group has a trailing twelve months EPS of $0.93.

PE Ratio

Hanover Insurance Group has a trailing twelve months price to earnings ratio of 138.57. Meaning, the purchaser of the share is investing $138.57 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.4%.

Sales Growth

Hanover Insurance Group’s sales growth is 3.1% for the ongoing quarter and 3.6% for the next.

Yearly Top and Bottom Value

Hanover Insurance Group’s stock is valued at $128.87 at 16:15 EST, under its 52-week high of $138.00 and way above its 52-week low of $103.83.

More news about Hanover Insurance Group.